- Home
- MBBC vs LTRN Comparison
MBBC vs LTRN Comparison
Compare MBBC & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBBC
- LTRN
- Stock Information
- Founded
- MBBC 1902
- LTRN 2013
- Country
- MBBC United States
- LTRN United States
- Employees
- MBBC N/A
- LTRN N/A
- Industry
- MBBC Banks
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- MBBC Finance
- LTRN Health Care
- Exchange
- MBBC Nasdaq
- LTRN Nasdaq
- Market Cap
- MBBC 30.8M
- LTRN 36.0M
- IPO Year
- MBBC N/A
- LTRN 2020
- Fundamental
- Price
- MBBC $10.40
- LTRN $4.49
- Analyst Decision
- MBBC
- LTRN Strong Buy
- Analyst Count
- MBBC 0
- LTRN 1
- Target Price
- MBBC N/A
- LTRN $25.00
- AVG Volume (30 Days)
- MBBC 3.2K
- LTRN 197.2K
- Earning Date
- MBBC 11-22-2025
- LTRN 11-06-2025
- Dividend Yield
- MBBC N/A
- LTRN N/A
- EPS Growth
- MBBC N/A
- LTRN N/A
- EPS
- MBBC 0.02
- LTRN N/A
- Revenue
- MBBC $6,885,334.00
- LTRN N/A
- Revenue This Year
- MBBC N/A
- LTRN N/A
- Revenue Next Year
- MBBC N/A
- LTRN N/A
- P/E Ratio
- MBBC $720.05
- LTRN N/A
- Revenue Growth
- MBBC 1.92
- LTRN N/A
- 52 Week Low
- MBBC $6.42
- LTRN $2.55
- 52 Week High
- MBBC $12.00
- LTRN $6.12
- Technical
- Relative Strength Index (RSI)
- MBBC 55.54
- LTRN 55.33
- Support Level
- MBBC $10.32
- LTRN $3.89
- Resistance Level
- MBBC $10.48
- LTRN $4.55
- Average True Range (ATR)
- MBBC 0.04
- LTRN 0.33
- MACD
- MBBC -0.01
- LTRN 0.02
- Stochastic Oscillator
- MBBC 54.55
- LTRN 79.22
About MBBC Marathon Bancorp Inc. Common Stock
Marathon Bancorp Inc is a Wisconsin-chartered savings bank. It is a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the Company's revenues come from interest income on loans and debt securities.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.